Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

TOSOH BIOSCIENCE

Tosoh Bioscience develops automated immunoassay and HPLC analyzers that provide testing for a broad menu of quality a... read more Featured Products: More products

Download Mobile App




Sickle Cell Trait Confounds Blood Sugar Readings

By LabMedica International staff writers
Posted on 23 Feb 2017
Sickle cell trait (SCT) is a genetic hemoglobin variant found in 8% to 10% of African-Americans and it occurs in people with one copy of the mutation because if they had two copies, that would result in sickle cell disease.

Hemoglobin A1c (HbA1c) is a common blood biomarker used to measure blood sugar over time, but it may not perform as accurately among African-Americans with sickle cell trait and could be leading to a systemic underestimation of blood sugar control among that population.

A team of scientists led by those at the Brown University School of Public Health performed a retrospective cohort study on data from two studies and the analytic sample included 4,620 participants (mean age, 52.3 ±11.8 years; 2,835 women (61.3%); 367 (7.9%) with SCT) with 9,062 concurrent measures of fasting glucose and HbA1c. More...
Analysis of the primary outcome was conducted using generalized estimating equations (GEE) to examine the association of SCT with HbA1c levels, controlling for fasting or 2-hour glucose measures.

Among all the patients included in the analysis, HbA1c readings came from either of two widely used, clinically accepted assays made by Tosoh Bioscience Inc. that rely on a process called high-performance liquid chromatography. In addition to those measures, the scientists also compared fasting and two-hour blood glucose and statistically controlled for demographic and medical factors, such as gender, age, body-mass index and whether diabetes had already been diagnosed and whether it was being treated.

The team found that using standard clinical HbA1c cutoffs resulted in identifying 40% fewer potential cases of prediabetes and 48% fewer potential cases of diabetes in people with SCT than in people without SCT. Meanwhile, when the scientists used other blood glucose measures as the diagnostic criteria, they found no significant difference in the likelihood of diabetes and prediabetes among patients with or without SCT. Current diagnostic thresholds for HbA1C are greater than 5.7% for prediabetes and greater than 6.5% for diabetes.

The authors of the study therefore recommend that practitioners following African-American patients whose HbA1c levels are within 0.3 percentage points of a diagnostic cutoff also consider using additional blood glucose measures. Gregory A.Wellenius, ScD, an associate professor of epidemiology and co-author of the study said, “The strengths of the study are that it's the largest sample size ever used, it's across two different studies with somewhat different populations, and it's a more thorough evaluation than prior studies.” The study was published on February 7, 2017, in the Journal of the American Medical Association (JAMA).


Gold Member
Hematology Analyzer
Medonic M32B
Portable Electronic Pipette
Mini 96
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.